CARA Message Board Post 9189054 | Cara Therapeutics Inc.
home / stock / cara / cara message board
mortonrj
(investorshub)
Posted on: Mar/02/2022 21:15:22
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168065544
Got some bounce today.
News, Short Squeeze, Breakout and More Instantly...
-
– Study achieved primary endpoint of Worst Itch-Numeric Rating Scale score change from baseline at Week 8 (p=0.001) – – Onset of action seen at Week 1 and sustained through Week 8 – – Statistical significance achieve...
-
KORSUVA™ (difelikefalin) injection U.S. commercial launch began in April 2022 and is tracking to expectation Kapruvia ® (difelikefalin) approved by European Commission for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...
-
STAMFORD, Conn., May 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President an...